Posted by Michael Wonder on 06 Feb 2017
Advanced therapy medicines: towards increased development and patient access
6 February 2017 - Follow-up activities addressing stakeholder needs.
The EMA has published today a set of ideas to better support development and expand patients’ access to high quality, safe and effective advanced therapy medicinal products (ATMPs).
The existing efforts in the area of ATMPs are enriched by these ideas that were developed following a multi-stakeholder expert meeting on advanced therapy medicines organised in May 2016, at which EMA, the European Commission and representatives from the national competent authorities explored together with stakeholders ways to encourage innovation, research and development.
